Novel Pathways and Molecular Targets for the Treatment of Sarcoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11912-013-0319-3.pdf
Reference85 articles.
1. •• von Mehren M, Benjamin RS, Bui MM, et al. Soft tissue sarcoma, version 2.2012: featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network 2012;10:951-60. The current treatment guidelines for sarcoma are detailed here and actively updated by committee.
2. Jemal A, Siegel R, Xu J, et al. Cancer Statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
3. • Rajendra R, Pollack SM, Jones RL. Management of gastrointestinal stromal tumors. Future Oncology 2013;9:193-206. This is a recent review on the management of GIST.
4. Jones B, Komarnitsky P, Miller GT, et al. Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin. Anti-Cancer Drugs. 2012;23:173–84.
5. Ganjoo KN, Cranmer LD, Butrynski JE, et al. A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma. Oncology. 2011;80:50–6.
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Revisiting 'Hallmarks of Cancer' In Sarcomas;Journal of Cancer;2024
2. Genetic context of oncogenic drivers dictates vascular sarcoma development in aP2‐Cre mice;The Journal of Pathology;2022-02-15
3. An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma;European Journal of Cancer;2021-09
4. Solitary Fibrous Tumor in the Perianal Region: Report of Two Cases With an Atypical Location;Cureus;2021-01-24
5. Eculizumab-Responsive Adult Onset Protein Losing Enteropathy, Caused by Germline CD55-Deficiency and Complicated by Aggressive Angiosarcoma;Journal of Clinical Immunology;2020-11-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3